HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 166 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,976,000 | -67.3% | 200,000 | -60.1% | 0.25% | -55.2% |
| Q3 2016 | $6,051,000 | -26.1% | 500,904 | -47.2% | 0.56% | -43.5% |
| Q2 2016 | $8,188,000 | -19.4% | 948,803 | -11.6% | 0.99% | -28.2% |
| Q1 2016 | $10,163,000 | -46.7% | 1,073,154 | -2.4% | 1.38% | -25.3% |
| Q4 2015 | $19,063,000 | +33.7% | 1,100,000 | +3.6% | 1.85% | +48.6% |
| Q3 2015 | $14,257,000 | -62.8% | 1,061,547 | -37.5% | 1.24% | -54.3% |
| Q2 2015 | $38,329,000 | +53.4% | 1,697,504 | -3.0% | 2.72% | +36.7% |
| Q1 2015 | $24,986,000 | -4.1% | 1,749,691 | -35.2% | 1.99% | +11.4% |
| Q4 2014 | $26,055,000 | +91.0% | 2,700,000 | +80.1% | 1.79% | +90.0% |
| Q3 2014 | $13,643,000 | +2.3% | 1,499,214 | +11.1% | 0.94% | +34.2% |
| Q2 2014 | $13,338,000 | – | 1,350,000 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |